Printer Friendly

Newly Identified Vascular Stem Cells Repair Blood Vessels.

OSAKA, Japan, February 15, 2018 -- Researchers here have identified vascular endothelial stem cells (VESCs) that can regenerate blood vessels and treat a rare bleeding disorder.

These VESCs have the potential to serve as a new cell-based therapy for blood vessel-related diseases.

The proper function of blood vessels is essential to life: blood vessels are responsible for transporting oxygen-rich red blood cells, nutrients, and immune cells throughout the body, to name just a few functions.

Defects in blood vessels can correspondingly lead to a variety of life-threatening diseases.

Stem cells, which are undifferentiated cells that can generate new tissues, have significant potential in regenerative medicine and treating various disorders.

In blood vessels, the existence of tissue-resident stem cells has been intensely debated. A research team centered at Osaka University may now have discovered the elusive stem cell, providing evidence for adult vascular endothelial stem cells (VESCs) capable of generating fully functional blood vessels.

The research team had previously identified a population of endothelial cells (ECs), isolated from the inner most layer of blood vessels, with properties resembling those of stem cells.

The cells were actually isolated by functional analysis, so the team was interested in finding molecular markers that specifically define endothelial stem cells.

The researchers looked for a cell-surface protein that is highly expressed in the endothelial stem-like population, but not in other ECs. When they found a clear stem marker of ECs, they were able to sort the cells based on the proteins expressed on their surface.

This would theoretically allow the researchers to isolate a homogeneous pool of candidate endothelial stem cells.

They found a highly abundant glycoprotein, called CD157, expressed in the small fraction of EC population. After isolating just the ECs that expressed CD157, they set out to determine whether they were truly VESCs.

The key characteristic of stem cells is their ability to regenerate themselves, so they hypothesized that the CD157-positive ECs would be able to form new blood vessels. They tested this idea by experimentally injuring mice, damaging the blood vessels that supply blood to the liver, and injecting them with CD157-positive ECs isolated from the liver.

The results were more than they could have hoped for. A month after transplantation, the CD157-enriched cells generated fully functional portal veins, portal venules, sinusoids, hepatic venules, and arteries, essentially every type of blood vessel found in a healthy liver. They followed up by injecting mice with just one cell each. The success rate was smaller, but even a single cell was enough to reconstitute their blood vessels.

In addition to repairing injured tissue, stem cells are crucial to maintaining healthy tissue. As further confirmation that they had discovered a VESC, the team used a fluorescent reporter to follow the fate of these cells in non-injured healthy mice.

A year later, the cells continued to replenish normal blood vessel tissue in the liver-precisely what would be expected of functioning, native stem cells.

Following the successful liver repair experiments, the team sought to determine how versatile the cells might be in treating other blood vessel-related diseases.

Hemophilia A, a rare bleeding disorder in which blood is unable to clot properly, is caused by a genetic mutation that prevents liver blood vessels from making clotting factor VIII (FVIII).

When VESCs collected from healthy mice were injected into mice with hemophilia A, the cells began generating new liver blood vessels--and the level of FVIII in the blood shot up, from less than one percent of normal to over 60 percent.

The therapeutic potential of these cells does not appear to be limited to liver defects. The researchers also used VESCs from muscle tissue to treat limb ischemia in mice, where a lack of oxygenated blood can lead to tissue damage and foot necrosis.

The study potentially represents a turning point in cell-based therapies for blood vessel disorders.

The findings show that CD157-positive vascular endothelial stem cells give rise to a hierarchy of cell types that can repair vascular injury and maintain the normal blood vessel architecture.

"We believe these findings represent an entirely new way of thinking about how blood vessels are formed and, ultimately, how stem cells can be used to treat disorders related to blood vessel malfunction," said researcher Nobuyuki Takakura.

Citation: Taku Wakabayashi et al., "CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties," Cell Stem Cell, 2018; DOI: 10.1016/j.stem.2018.01.010

Abstract/Article: http://bit.ly/2ow4q3U

Contact: Nobuyuki Takakura, ntakaku@biken.osaka-u.ac.jp
COPYRIGHT 2018 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Basic Research
Publication:Stem Cell Research News
Date:Feb 26, 2018
Words:745
Previous Article:Stem Cell Mutations Found To Impede Muscle Repair.
Next Article:Lab-Grown Human Cerebellar Cells Enable Study Of Autism.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters